The EU approved AstraZeneca's Enhertu for certain breast cancer patients and Imfinzi for resectable NSCLC, showing ...

Ms Brown's daughter, Megan Johnson, 29, said a drug treatment called Phesgo had changed her mum's life and allowed her to ...

Seth Wander, MD, PhD, discusses the tolerability of selective estrogen receptor degraders and next-generation anti-estrogen ...

C, provided insights on what to consider when treating patients with HR+, HER2- breast cancer in the second line of treatment.

Kaplan–Meier curves showed that extended adjuvant pyrotinib administered after trastuzumab-based adjuvant therapy provides a promising survival benefit in patients with high-risk HER2-positive breast ...

Jim Willwerth, in this horticulture discussion, delves into hormonal therapy for grapevines, including plant growth ...

HealthDay News — Some commonly prescribed photosensitizing drugs increase skin cancer risk, according to a study published online March 18 in Photodermatology, Photoimmunology & Photomedicine.

Some commonly prescribed photosensitizing drugs increase skin cancer risk, according to a study published online March 18 in ...

Most women with breast cancer who paused endocrine therapy to get pregnant did not restart treatment after having a child, ...

Research from Weill Cornell Medicine has identified a molecular pathway linking omega-6 linoleic acid—a common dietary fat in ...

A team has developed a new way to quickly find personalized treatments for young cancer patients, by growing their tumors in chicken eggs and analyzing their proteins. The team has combined these two ...

The U.S Food & Drug Administration has granted approval for a targeted therapy called CABOMETYX ® to treat pancreatic ...